Please wait a minute...
Advanced Search
数据分析与知识发现  2022, Vol. 6 Issue (7): 70-86     https://doi.org/10.11925/infotech.2096-3467.2021.1263
  研究论文 本期目录 | 过刊浏览 | 高级检索 |
基于在线健康社区的药物不良反应信号识别方法研究*
郭进京1,夏光辉2(),黄奇1,何丽云3,张化冰3
1南京大学信息管理学院 南京 210023
2中国医学科学院医学信息研究所 北京 100020
3中国医学科学院北京协和医院 北京 100730
Detecting Signals of Adverse Drug Reactions with Data from Online Health Community
Guo Jinjing1,Xia Guanghui2(),Huang Qi1,He Liyun3,Zhang Huabing3
1School of Information Management, Nanjing University, Nanjing 210023, China
2Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing 100020, China
3Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
全文: PDF (981 KB)   HTML ( 15 ) 
输出: BibTeX | EndNote (RIS)      
摘要 

【目的】在线健康社区为药物不良反应信号监测提供了新的信息源,从患者对不良反应的评论数据中识别药物不良反应信号有助于为抗糖尿病类药物不良反应的监测预警提供参考。【方法】以Ask a Patient网站中患者的抗糖尿病药物不良反应评论为数据源,结合自然语言处理技术和UMLS、MedDRA等词表对患者评论数据进行规范化处理和映射,构建药物-不良反应共现矩阵,采用PRR法识别符合信号监测阈值的药物-不良反应对并对抽取结果进行专家判读,最后以Drugs.com作为金标准对方法的有效性进行评估。【结果】共计识别出539组药物-不良反应对,整体识别准确率达85%,金标准整体吻合率达82%,说明该方法具有一定的有效性。【局限】 因MedDRA中纳入了部分检查、手术操作、社会环境等类型的与ADR无关的术语,对ADR术语的识别准确率产生一定影响。【结论】本研究采用的药物不良反应信号识别思路,丰富了药物不良反应信号监测渠道和方法,为药物不良反应信号监测提供了参考。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
郭进京
夏光辉
黄奇
何丽云
张化冰
关键词 ： 在线健康社区,  知识发现,  比例报告比法,  药物不良反应    
Abstract：

[Objective] Online health communities provide new information for detecting adverse drug reaction (ADR) signals. This study identifies ADR signals from patients’ reviews and generates early warnings for potential side-effects of antidiabetic drugs. [Methods] First, we retrieved patients’ reviews (adverse reactions) on antidiabetic drugs from Ask a Patient website. Then, we combined natural language processing techniques and lexicons (UMLS and MedDRA) to normalize and map these reviews. Third, we constructed a drug-ADR co-occurrence matrix and used the PRR method to identify drug-ADR pairs meeting the signal detection threshold. Finally, we invited expert to interpret the extracted results, which were evaluated with Drugs.com standards. [Results] A total of 539 drug-ADR pairs were identified, with an overall identification accuracy of 85% and recall of 82%. [Limitations] The accuracy of identifying ADR terms was affected by the inclusion of non-ADR terms, such as examination, surgical operation, and social environment from MedDRA. [Conclusions] The proposed model enriches the data sources and methods of ADR signal detection.
Key words： Online Health Community    Knowledge Discovery    Proportional Reporting Ratio    Adverse Drug Reaction
收稿日期: 2021-11-04      出版日期: 2022-08-24
ZTFLH:  G250  
基金资助:*国家自然科学基金项目(91846106);中国医学科学院中央级公益性科研院所基本科研业务费项目的研究成果之一(2019XK320029)
通讯作者: 夏光辉,ORCID:0000-0003-4587-0344     E-mail: xiagh@imicams.ac.cn
引用本文:   
郭进京, 夏光辉, 黄奇, 何丽云, 张化冰. 基于在线健康社区的药物不良反应信号识别方法研究*[J]. 数据分析与知识发现, 2022, 6(7): 70-86.
Guo Jinjing, Xia Guanghui, Huang Qi, He Liyun, Zhang Huabing. Detecting Signals of Adverse Drug Reactions with Data from Online Health Community. Data Analysis and Knowledge Discovery, 2022, 6(7): 70-86.
链接本文:  
https://manu44.magtech.com.cn/Jwk_infotech_wk3/CN/10.11925/infotech.2096-3467.2021.1263      或      https://manu44.magtech.com.cn/Jwk_infotech_wk3/CN/Y2022/V6/I7/70
Fig.1  基于在线健康社区的药物不良反应信号识别
Fig.2  抗糖尿病药物不良反应信号识别过程及结果
序号 中文通用名 英文名 商品名 药品种类 评论数
1 阿托伐他汀 atorvastatin LIPITOR 降脂药 1 244
2 阿仑膦酸钠 alendronate sodium FOSAMAX 抗甲状旁腺药、钙磷代谢调节药及抗骨质疏松药 1 208
3 瑞舒伐他汀 rosuvastatin CRESTOR 降脂药 1 208
4 辛伐他汀 simvastatin ZOCOR 降脂药 891
5 左甲状腺素钠 levothyroxine sodium SYNTHROID 甲状腺激素及其抗甲状腺药物 887
6 二甲双胍 metformin GLUCOPHAGE 胰岛素及口服降糖药 582
7 依折麦布 ezetimibe ZETIA 降脂药 537
8 吡格列酮 pioglitazone ACTOS 胰岛素及口服降糖药 360
9 非诺贝特 fenofibrate TRICOR 降脂药 325
10 利拉鲁肽 liraglutide VICTOZA 胰岛素及口服降糖药 244
11 普伐他汀 pravastatin PRAVACHOL 降脂药 225
12 艾塞那肽 exenatide BYETTA 胰岛素及口服降糖药 206
13 唑来膦酸 zoledronic acid RECLAST 抗甲状旁腺药、钙磷代谢调节药及抗骨质疏松药 184
14 罗格列酮 rosiglitazone AVANDIA 胰岛素及口服降糖药 99
15 西格列汀 sitagliptin JANUVIA 胰岛素及口服降糖药 98
16 胰岛素 insulin LANTUS 胰岛素及口服降糖药 94
17 度拉糖肽 dulaglutide TRULICITY 胰岛素及口服降糖药 56
18 溴隐亭 bromocriptine PARLODEL 下丘脑垂体疾病及其用药 53
Table 1  经过筛选后的抗糖尿病药物列表
处理参数 值
Knowledge Source 2020AB
Data Version NLM
Data Model Relaxed Model
Show CUIs yes
Use Word Sense Disambiguation yes
Restrict to Sources COSTAR, MDR, WHO
Table 2  MetaMap数据处理参数

ADRi

ADDj		 1-阿托伐他汀-LIPITOR 2-阿仑膦酸钠-FOSA
MAX		 3-瑞舒伐他汀-CREST
OR		 … 18-溴隐亭-PAR
LODEL
Abdominal bloating 21 61 34 … 1
Abdominal cramps 4 5 1 … 1
Abdominal discomfort 0 0 2 …… 0
… … … … … …
Yeast
infection		 0 1 0 … 0
Table 3  ADR与ADD的共现矩阵
特定ADD 数据集中所有其他ADD
特定ADR a c
所有其他ADR b d
Table 4  PRR方法的计算四格表法
序号 1-阿托伐他汀-LIPITOR 2-阿仑膦酸钠-FOSAMAX 3-瑞舒伐他汀-CRESTOR
ADRs PRR ADRs PRR ADRs PRR
1 Parkinson’s disease 34.46 Osteonecrosis of jaw 28.67 Feeling of despair 15.89
2 Cataract 22.97 Osteopenia 22.94 Tietze’s Syndrome 15.89
3 Nerve injury 20.10 Pain in thumb 22.94 Tenderness muscle 15.89
4 Shoulder operation 17.23 Root canal procedure 17.20 Electric shock 15.89
5 Fatty liver 14.36 Bone necrosis 17.20 Renal function test 7.95
6 Biopsy 11.49 Pelvic pain female 17.20 Interventional procedure 7.95
7 Clumsiness 11.49 Angiogram NOS 17.20 Mixed anxiety and depressive disorder 7.06
8 Neck cramps 9.57 Osteoporosis 14.75 Radiating pain 5.30
9 Depression suicidal 8.62 Eye pain 13.93 Aggressive behavior 4.64
10 Hypersomnia 8.62 Bone scan NOS 13.76 Lipids NOS 4.54
序号 4-辛伐他汀-ZOCOR 5-左甲状腺素钠-SYNTHROID 6-二甲双胍-GLUCOPHAGE
ADRs PRR ADRs PRR ADRs PRR
1 Nodule 15.20 Hypothyroidism 69.46 Acidosis lactic 99.72
2 Oliguria 15.20 Graves’ disease 57.89 Gastrointestinal symptom NOS 79.78
3 Muscle mass 15.20 Goiter 48.24 Fecal Incontinence 59.83
4 Shooting pain 12.16 Behavior hyperactive 45.02 Polycystic ovary 49.86
5 Angina pectoris 11.40 Dry skin 35.62 Soft stools 39.89
6 Chest X-ray 10.13 Racing thoughts 28.94 Explosive diarrhoea 34.19
7 Lack of libido 8.26 Irregular menstruation 28.94 Taste metallic 32.64
8 Faeces clay-coloured 7.60 Infertility 28.94 Loose stools 31.53
9 Lymphadenopathy 7.60 Cold intolerance 28.94 Gastrointestinal irritation 29.92
10 Back surgery 7.60 Overactive 28.94 Diarrhea 15.27
序号 7-依折麦布-ZETIA 8-吡格列酮-ACTOS 9-非诺贝特-TRICOR
ADRs PRR ADRs PRR ADRs PRR
1 Nasal sinus congestion 30.56 Leg edema 95.61 Biliary colic 82.26
2 Pulmonary congestion 19.65 Dry cough 28.68 Fish-eye disease 20.56
3 Diverticulitis 13.10 Ankle edema 27.52 Prurigo 15.67
4 Weird feeling 9.82 Body fluid retention 22.31 Slurred speech 7.48
5 Inflammation mucous membrane 7.86 Anemia 21.73 Pain in joint involving hand 7.22
6 Upper GI series 7.86 Swelling of legs 21.51 Skin greasy 5.96
7 Chest pressure 7.49 Congestive heart failure 18.59 CAT scan 4.99
8 Constriction throat 6.55 Water retention 17.93 Pain in elbow 4.99
9 Cardiac flutter 6.55 Swelling of tongue 17.93 Influenza-like symptoms 3.10
10 Gas pain 5.95 Severe pre-eclampsia 14.71 Blood test NOS 2.81
序号 10-利拉鲁肽-VICTOZA 11-普伐他汀-PRAVACHOL 12-艾塞那肽-BYETTA
ADRs PRR ADRs PRR ADRs PRR
1 Nausea and vomiting 73.65 Cardiac pain 16.04 Injection site bruising 275.61
2 Pancreatitis 49.10 Pain dull 6.80 Injection 24.65
3 Bad taste 23.01 Nephritis 6.07 Bite 18.37
4 Eructation 22.25 Hepatic enzyme 4.88 Anorexia 13.78
5 Vomiting 9.99 Forgetfulness 4.32 Vomiting 10.71
6 Dehydration 7.01 Libido decreased 4.28 Gas pain 10.60
7 Rhinorrhea 6.90 Confusion 3.51 Redness 9.19
8 Irritable bowel syndrome 6.50 Tinnitus 3.12 Nausea 9.10
9 Nausea 6.02 Muscle weakness 2.93 Weight decreased 8.52
10 Stomach cramps 5.71 Memory loss 2.67 Contusion 8.35
序号 13-唑来膦酸-RECLAST 14-罗格列酮-AVANDIA 15-西格列汀-JANUVIA
ADRs PRR ADRs PRR ADRs PRR
1 Infusion 772.22 Infection 90.96 Rhinorrhea 21.04
2 Exostosis 119.83 Congestive heart failure 41.35 Poor weight gain 15.30
3 Femur fracture 59.91 Water retention 36.39 Upper respiratory infection 13.60
4 Kidney failure 23.97 Sluggishness 30.32 No adverse effect 9.05
5 Fever 15.32 Heart fluttering 27.29 Pharyngitis 8.77
6 Paronychia 11.41 Electrocardiogram 24.81 Coughing 5.26
7 Breathing abnormally deep 9.99 Foot edema 24.64 Tachycardia 4.43
8 Flu symptoms 9.99 Hypoglycemia 22.74 Anxiety 3.21
9 Fracture 9.59 Heart rate irregular 21.40
10 Bone pain 9.44 Edema 14.08
序号 16-胰岛素-LANTUS 17-度拉糖肽-TRULICITY 18-溴隐亭-PARLODEL
ADRs PRR ADRs PRR ADRs PRR
1 Fire accident 38.75 Explosive diarrhoea 34.37 Hallucinations 217.27
2 Burn 31.00 Injection 18.74 Nose congestion 81.48
3 Hypoglycemia 22.15 Dehydration 17.57 Hypotension 59.26
4 Injection 14.53 Eructation 17.06 Syncope 27.94
5 Hunger 8.21 Appetite absent 11.48 Vomiting 7.27
6 Burning sensation 6.64 Vomiting 8.37 Vertigo 5.95
7 Edema 5.00 Illness 7.81 Dizziness 5.24
8 Constipation 3.42 Sweating 5.02 Palpitations 5.17
9 Pruritus 3.32 Abdominal pain 4.77 Drowsiness 4.71
10 Weight 3.29 Nausea 4.73 Nausea 3.94
Table 5  18种ADD所对应的ADRs及其PRR值（Top-10）
序号 1-阿托伐他汀-LIPITOR 2-阿仑膦酸钠-FOSAMAX 3-瑞舒伐他汀-CRESTOR
ADR PRR ADR PRR ADR PRR
1 Parkinson’s disease 34.46 Osteonecrosis of jaw* 28.67 Feeling of despair* 15.89
2 Cataract 22.97 Osteopenia 22.94 Tietze’s Syndrome 15.89
3 Nerve injury* 20.10 Pain in thumb* 22.94 Tenderness muscle* 15.89
4 Fatty liver 14.36 Bone necrosis* 17.20 Electric shock 15.89
5 Clumsiness 11.49 Pelvic pain female 17.20 Mixed anxiety and depressive disorder* 7.06
6 Neck cramps* 9.57 Osteoporosis* 14.75 Radiating pain 5.30
7 Depression suicidal* 8.62 Eye pain* 13.93 Aggressive behavior* 4.64
8 Hypersomnia* 8.62 Jaw pain* 11.72 Bad dreams* 4.54
9 Atrophy NOS 8.62 Gastric ulcer* 11.47 Sore feet* 4.33
10 Unspecified visual loss* 8.62 Stiffness hip* 10.04 Sleep disturbances* 3.97
Recall 0.50 0.80 0.70
序号 4-辛伐他汀-ZOCOR 5-左甲状腺素钠-SYNTHROID 6-二甲双胍-GLUCOPHAGE
ADR PRR ADR PRR ADR PRR
1 Nodule* 15.20 Graves’ disease* 57.89 Acidosis lactic* 99.72
2 Oliguria 15.20 Goiter* 48.24 Gastrointestinal symptom NOS* 79.78
3 Shooting pain* 12.16 Behavior hyperactive* 45.02 Fecal Incontinence* 59.83
4 Angina pectoris* 11.40 Dry skin 35.62 Soft stools* 39.89
5 Lack of libido* 8.26 Racing thoughts 28.94 Explosive diarrhoea* 34.19
6 Faeces clay-coloured* 7.60 Irregular menstruation* 28.94 TASTE METALLIC 32.64
7 Lymphadenopathy 7.60 Infertility* 28.94 Loose stools* 31.53
8 Neuralgia* 7.60 Cold intolerance* 28.94 Gastrointestinal irritation* 29.92
9 Frozen shoulder* 5.70 Overactive* 28.94 Diarrhea* 15.27
10 Muscle tightness* 5.07 Premenstrual syndrome 24.12 Thirst 13.30
Recall 0.80 0.70 0.80
序号 7-依折麦布-ZETIA 8-吡格列酮-ACTOS 9-非诺贝特-TRICOR
ADR PRR ADR PRR ADR PRR
1 Nasal sinus congestion* 30.56 Leg edema* 95.61 Biliary colic* 82.26
2 Pulmonary congestion 19.65 Dry cough* 28.68 Fish-eye disease* 20.56
3 Diverticulitis 13.10 Ankle edema* 27.52 Prurigo* 15.67
4 Weird feeling* 9.82 Body fluid retention* 22.31 Slurred speech 7.48
5 Inflammation mucous membrane 7.86 Anemia* 21.73 Pain in joint involving hand* 7.22
6 Constriction throat* 6.55 Swelling of legs* 21.51 Skin greasy 5.96
7 Cardiac flutter 6.55 Congestive heart failure* 18.59 Pain in elbow* 4.99
8 Gas pain* 5.95 Water retention* 17.93 Influenza-like symptoms* 3.10
9 Pain-left side* 5.24 Swelling of tongue* 17.93 Vertigo* 2.76
10 Increased frequency of defecation* 4.91 Severe pre-eclampsia 14.71 Exanthema* 2.49
Recall 0.60 0.90 0.80
序号 10-利拉鲁肽-VICTOZA 11-普伐他汀-PRAVACHOL 12-艾塞那肽-BYETTA
ADR PRR ADR PRR ADR PRR
1 Nausea and vomiting* 73.65 Cardiac pain* 16.04 Injection site bruising* 275.61
2 Pancreatitis* 49.10 Pain dull* 6.80 Anorexia 13.78
3 Bad taste* 23.01 Nephritis 6.07 Vomiting* 10.71
序号 10-利拉鲁肽-VICTOZA 11-普伐他汀-PRAVACHOL 12-艾塞那肽-BYETTA
ADR PRR ADR PRR ADR PRR
4 Eructation* 22.25 Forgetfulness* 4.32 Gas pain* 10.60
5 Vomiting* 9.99 Libido decreased* 4.28 Redness* 9.19
6 Dehydration* 7.01 Confusion* 3.51 Nausea* 9.10
7 Rhinorrhea 6.90 Tinnitus* 3.12 Weight decreased* 8.52
8 Irritable bowel syndrome* 6.50 Muscle weakness* 2.93 Feeling jittery* 8.11
9 Nausea* 6.02 Memory loss* 2.67 Ataxia Telangiectasia 7.07
10 Stomach cramps* 5.71 Hypoglycemia* 6.26
Recall 0.90 0.89 0.80
序号 13-唑来膦酸-RECLAST 14-罗格列酮-AVANDIA 15-西格列汀-JANUVIA
ADR PRR ADR PRR ADR PRR
1 Exostosis 119.83 Infection* 90.96 Rhinorrhea 21.04
2 Femur fracture* 59.91 Congestive heart failure* 41.35 Poor weight gain 15.30
3 Kidney failure* 23.97 Water retention* 36.39 Upper respiratory infection* 13.60
4 Fever* 15.32 Sluggishness 30.32 Pharyngitis* 8.77
5 Paronychia 11.41 Heart fluttering 27.29 Coughing* 5.26
6 Breathing abnormally deep* 9.99 Foot edema* 24.64 Tachycardia* 4.43
7 Flu symptoms* 9.99 Hypoglycemia* 22.74 Anxiety* 3.21
8 Fracture* 9.59 Heart rate irregular* 21.40
9 Bone pain* 9.44 Edema* 14.08
10 Inguinal pain 8.56 Ankle edema* 8.40
Recall 0.70 0.80 0.71
序号 16-胰岛素-LANTUS 17-度拉糖肽-TRULICITY 18-溴隐亭-PARLODEL
ADR PRR ADR PRR ADR PRR
1 Hypoglycemia* 22.15 Explosive diarrhoea* 34.37 Hallucinations* 217.27
2 Hunger* 8.21 Dehydration* 17.57 Nose congestion* 81.48
3 Burning sensation* 6.64 Eructation* 17.06 Hypotension* 59.26
4 Edema* 5.00 Appetite absent* 11.48 Syncope* 27.94
5 Constipation* 3.42 Vomiting* 8.37 Vomiting* 7.27
6 Pruritus* 3.32 Illness* 7.81 Vertigo* 5.95
7 Weight gain* 3.06 Sweating* 5.02 Dizziness* 5.24
8 Abdominal pain* 4.77 Palpitations* 5.17
9 Nausea* 4.73 Drowsiness* 4.71
10 Diarrhea* 4.34 Nausea* 3.94
Recall 1.00 1.00 1.00
Table 6  修正后的18种ADD所对应的ADRs及其PRR值（Top-10）
序号 中文通用名 评论数 符合初筛条件
的ADR		 专家判定后
的ADR		 覆盖金
标准数		 ADR术语识别
准确率		 Recall
（Top-10）		 Reall
（all）
1 阿托伐他汀 1 244 45 38 28 0.84 0.50 0.74
2 阿仑膦酸钠 1 208 62 48 34 0.77 0.80 0.71
3 瑞舒伐他汀 1 208 34 29 25 0.85 0.70 0.86
4 辛伐他汀 891 42 34 28 0.81 0.80 0.82
5 左甲状腺素钠 887 78 72 57 0.92 0.70 0.79
6 二甲双胍 582 40 34 30 0.85 0.80 0.88
7 依折麦布 537 28 24 16 0.86 0.60 0.67
8 吡格列酮 360 35 32 26 0.91 0.90 0.81
9 非诺贝特 325 15 12 10 0.80 0.80 0.83
10 利拉鲁肽 244 29 27 24 0.93 0.90 0.89
11 普伐他汀 225 10 9 8 0.90 0.89 0.89
12 艾塞那肽 206 27 21 19 0.78 0.80 0.90
13 唑来膦酸 184 29 23 18 0.79 0.70 0.78
14 罗格列酮 99 21 17 15 0.81 0.80 0.88
15 西格列汀 98 8 7 5 0.88 0.71 0.71
16 胰岛素 94 11 7 7 0.64 1.00 0.88
17 度拉糖肽 56 14 12 12 0.86 1.00 1.00
18 溴隐亭 53 11 11 11 1.00 1.00 1.00
总计 539 457 373 0.85 0.82
Table 7  18种ADD的所有ADR与金标准的吻合情况计算结果
序号 ADD ADR PRR 共现频次
1 阿托伐他汀-LIPITOR Parkinson’s disease 34.46 6
Cataract 22.97 4
Fatty liver 14.36 5
Clumsiness 11.49 4
Atrophy NOS 8.62 3
Lupus erythematosus 8.62 4
Atrophy skeletal muscle 5.74 4
Cerebration impaired 3.38 10
Restless legs syndrome 3.06 8
Scheuermann’s disease 2.26 22
2 阿仑膦酸钠-FOSAMAX Osteopenia 22.94 40
Pelvic pain female 17.20 3
Drug reaction with eosinophilia and systemic symptoms 10.04 7
Bone spur 8.60 3
Dislocation 8.60 3
Gingival pain 7.17 5
Malignant breast neoplasm 5.73 4
Muscle stiffness 4.81 47
Sciatica 3.32 11
Stiffness 3.24 48
Decompression sickness 3.19 15
Atrial fibrillation 3.13 6
Joint stiffness 2.87 10
Laceration 2.37 12
3 瑞舒伐他汀-CRESTOR Tietze’s Syndrome 15.89 3
Electric shock 15.89 3
Radiating pain 5.30 4
Gout 3.71 7
4 辛伐他汀-ZOCOR Oliguria 15.20 4
Lymphadenopathy 7.60 4
Bursitis 4.84 7
Mg++ increased 3.80 5
Heterosexuality 3.62 10
Shock 2.80 7
5 左甲状腺素钠-SYNTHROID Dry skin 35.62 48
Racing thoughts 28.94 3
Premenstrual syndrome 24.12 5
Dry hair 16.08 5
Carpal tunnel syndrome 9.65 6
Endometriosis 9.65 5
Hashimoto’s disease 9.65 3
Photophobia 8.04 5
Suicide 6.43 4
Hypertrichosis 4.70 39
Drying 4.48 13
Dryness of eyes 4.29 12
Upper respiratory infection 3.57 10
Cerebration impaired 3.38 7
Libido decreased 2.89 9
6 二甲双胍-GLUCOPHAGE Taste metallic 32.64 18
Thirst 13.30 10
Arsenical keratosis 2.78 6
Hypertrichosis 2.45 13
7 依折麦布-ZETIA Pulmonary congestion 19.65 3
Diverticulitis 13.10 3
Inflammation mucous membrane 7.86 3
Cardiac flutter 6.55 5
Night sweats 4.37 11
Middle insomnia 4.37 6
Anxiety attack 4.09 5
Bursitis 3.74 4
8 吡格列酮-ACTOS Severe pre-eclampsia 14.71 8
Increased appetite 7.03 5
Dyspnea 6.66 44
Mg++ increased 5.98 3
Epistaxis 5.98 3
Renal pain 5.12 3
9 非诺贝特-TRICOR Slurred speech 7.48 3
Skin greasy 5.96 5
10 利拉鲁肽-VICTOZA Rhinorrhea 6.90 3
Ataxia Telangiectasia 5.67 4
Xerostomia 3.92 5
11 普伐他汀-PRAVACHOL Nephritis 6.07 6
12 艾塞那肽-BYETTA Anorexia 13.78 3
Ataxia Telangiectasia 7.07 4
13 唑来膦酸-RECLAST Exostosis 119.83 3
Paronychia 11.41 4
Inguinal pain 8.56 3
Death NOS 4.56 4
Heterosexuality 4.28 3
14 罗格列酮-AVANDIA Sluggishness 30.32 4
Heart fluttering 27.29 3
15 西格列汀-JANUVIA Rhinorrhea 21.04 3
Poor weight gain 15.30 3
Table 8  部分需要关注的ADR警戒信号
[1] 魏巍. 药物不良反应知识发现与利用模型研究[D]. 武汉: 武汉大学, 2017.
[1] ( Wei Wei. Study on the Model of Knowledge Discovery and Utilization in Adverse Drug Reaction[D]. Wuhan: Wuhan University, 2017.)
[2] Yang C C, Yang H D, Jiang L. Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media[J]. ACM Transactions on Management Information Systems, 2014, 5(1): 1-21.
[3] Pappa D, Stergioulas L K. Harnessing Social Media Data for Pharmacovigilance: A Review of Current State of the Art, Challenges and Future Directions[J]. International Journal of Data Science and Analytics, 2019, 8(2): 113-135.
doi: 10.1007/s41060-019-00175-3
[4] World Health Organization‎. The Importance of Pharmacovigilance[EB/OL]. [2021-10-25]. https://apps.who.int/iris/bitstream/handle/10665/42493/a75646.pdf?sequence=1&isAllowed=y.
[5] World Health Organization‎. Guidelines for Good Clinical Practice(GCP) for Trials on Pharmaceutical Products[EB/OL]. [2021-10-25]. https://digicollections.net/medicinedocs/printable-whozip13e#d/whozip13e.
[6] World Health Organization. WHO Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems[EB/OL]. [2021-10-25]. https://apps.who.int/iris/bitstream/handle/10665/43034/9241592214_eng.pdf.
[7] Han J, Kamber M, Pei J. Data Mining: Concepts and Techniques[M]. The 3rd Edition. Waltham: Elsevier, 2012: 5-8.
[8] Karapetiantz P, Bellet F, Audeh B, et al. Descriptions of Adverse Drug Reactions are Less Informative in Forums than in the French Pharmacovigilance Database but Provide More Unexpected Reactions[J]. Frontiers in Pharmacology, 2018, 9: 439.
doi: 10.3389/fphar.2018.00439 pmid: 29765326
[9] Government of Canada. About GPHIN[EB/OL]. [2021-10-25] https://gphin.canada.ca/cepr/aboutgphin-rmispenbref.jsp?language=en_CA.
[10] Leaman R, Wojtulewicz L, Sullivan R, et al. Towards Internet-Age Pharmacovigilance: Extracting Adverse Drug Reactions from User Posts to Health-Related Social Networks[C]// Proceedings of the 2010 Workshop on Biomedical Natural Language Processing. 2010: 117-125.
[11] Sarker A, Ginn R, Nikfarjam A, et al. Utilizing Social Media Data for Pharmacovigilance: A Review[J]. Journal of Biomedical Informatics, 2015, 54: 202-212.
doi: 10.1016/j.jbi.2015.02.004 pmid: 25720841
[12] Sarker A, Ginn R, Nikfarjam A, et al. Mining Twitter for Adverse Drug Reaction Mentions: A Corpus and Classification Benchmark[C]// Proceedings of the 4th Workshop on Building and Evaluating Resources for Health and Biomedical Text Processing. 2014.
[13] Tang Y X, Yang J S, Ang P S, et al. Detecting Adverse Drug Reactions in Discharge Summaries of Electronic Medical Records Using Readpeer[J]. International Journal of Medical Informatics, 2019, 128: 62-70.
doi: 10.1016/j.ijmedinf.2019.04.017
[14] 赵明珍, 林鸿飞, 徐博, 等. 面向社交网络的潜在药物不良反应发现[J]. 中文信息学报, 2017, 31(5): 194-202.
[14] ( Zhao Mingzhen, Lin Hongfei, Xu Bo, et al. Potential Adverse Drug Reactions Discovery from Social Networks[J]. Journal of Chinese Information Processing, 2017, 31(5): 194-202.)
[15] Rezaei Z, Ebrahimpour-Komleh H, Eslami B, et al. Adverse Drug Reaction Detection in Social Media by Deep Learning Methods[J]. Cell Journal, 2020, 22(3): 319-324.
doi: 10.22074/cellj.2020.6615 pmid: 31863657
[16] Yogita, Sangma J W, Anal S R N, et al. Clustering-Based Hybrid Approach for Identifying Quantitative Multidimensional Associations Between Patient Attributes, Drugs and Adverse Drug Reactions[J]. Interdisciplinary Sciences, Computational Life Sciences, 2020, 12(3): 237-251.
doi: 10.1007/s12539-020-00365-9
[17] Harpaz R, DuMouchel W, Shah N H, et al. Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis[J]. Clinical Pharmacology & Therapeutics, 2012, 91(6): 1010-1021.
[18] Karapetiantz P, Audeh B, Lillo-Le Louët A, et al. Signal Detection for Baclofen in Web Forums: A Preliminary Study[J]. Studies in Health Technology and Informatics, 2018, 247: 421-425.
pmid: 29677995
[19] 朱晓旭, 林鸿飞, 曾泽渊. 基于社交媒体的药物不良反应检测[J]. 山西大学学报(自然科学版), 2020, 43(1): 14-21.
[19] Zhu Xiaoxu, Lin Hongfei, Zeng Zeyuan. Social Media-Based Adverse Drug Reaction Detection[J]. Journal of Shanxi University(Natural Science Edition), 2020, 43(1): 14-21.)
[20] 李嘉, 张朋柱, 吕英杰, 等. 电子健康挖掘研究述评[J]. 医学信息学杂志, 2013, 34(5): 13-20.
[20] ( Li Jia, Zhang Pengzhu, Lv Yingjie, et al. Review on Electronic Health Mining Research[J]. Journal of Medical Informatics, 2013, 34(5): 13-20.)
[21] 林鑫, 郭进京, 任慧玲. 药品不良反应术语系统构建探析[J]. 医学信息学杂志, 2019, 40(6): 60-65.
[21] ( Lin Xin, Guo Jinjing, Ren Huiling. Analysis of the Building of Adverse Drug Reaction Term System[J]. Journal of Medical Informatics, 2019, 40(6): 60-65.)
[22] Hammond I W, Rich D S, Gibbs T G. Effect of Consumer Reporting on Signal Detection: Using Disproportionality Analysis[J]. Expert Opinion on Drug Safety, 2007, 6(6): 705-712.
pmid: 17967159
[23] 孙亚林, 李永昌, 杜文民, 等. 药物警戒中不相称性测定理论应用问题分析[J]. 药物流行病学杂志, 2009, 18(3): 147-150.
[23] ( Sun Yalin, Li Yongchang, Du Wenmin, et al. Analysis of Application of Disproportional Measures in Pharmacovigilance[J]. Chinese Journal of Pharmacoepidemiology, 2009, 18(3): 147-150.)
[24] Evans S J W, Waller P C, Davis S. Use of Proportional Reporting Ratios(PRRS) for Signal Generation from Spontaneous Adverse Drug Reaction Reports[J]. Pharmacoepidemiology and Drug Safety, 2001, 10(6): 483-486.
pmid: 11828828
[25] van Puijenbroek E P, Bate A, Leufkens H G M, et al. A Comparison of Measures of Disproportionality for Signal Detection in Spontaneous Reporting Systems for Adverse Drug Reactions[J]. Pharmacoepidemiology and Drug Safety, 2002, 11(1): 3-10.
pmid: 11998548
[26] Bate A, Lindquist M, Edwards I R, et al. A Bayesian Neural Network Method for Adverse Drug Reaction Signal Generation[J]. European Journal of Clinical Pharmacology, 1998, 54(4): 315-321.
pmid: 9696956
[27] DuMouchel W, Pregibon D. Empirical Bayes Screening for Multi-Item Associations[C]// Proceedings of the 7th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2001: 57-76.
[28] International Diabetes Federation. Diabetes Around the World in 2021[EB/OL]. [2021-11-19]. https://diabetesatlas.org/idfawp/resource-files/2021/11/IDFDA10-global-fact-sheet.pdf.
[29] International Diabetes Federation. Diabetes in Western Pacific in 2021[EB/OL]. [2021-11-19]. https://diabetesatlas.org/idfawp/resource-files/2021/11/IDF-Atlas-Factsheet-2021_WP.pdf.
[30] 汤文璐, 王永铭, 杜文民, 等. 国内42年文献源抗糖尿病药物的不良反应分析[J]. 中国新药与临床杂志, 2002, 21(12): 753-758.
[30] ( Tang Wenlu, Wang Yongming, Du Wenmin, et al. Analysis of Adverse Drug Reaction of Antidiabetic Agents According to Documents within Forty-Two Years in China[J]. Chinese Journal of New Drugs and Clinical Remedies, 2002, 21(12): 753-758.)
[31] 印成霞, 许凤泉. 糖尿病类药物使用及不良反应的统计分析[J]. 中国实用医药, 2020, 15(1): 179-180.
[31] ( Yin Chengxia, Xu Fengquan. Analysis of the Use and Adverse Reaction of Diabetic Drugs[J]. China Practical Medicine, 2020, 15(1): 179-180.)
[32] James f, Kasia L. Metformin in 2019[J]. The Journal of the American Medical Association, 2019, 321(19): 1926-1927.
doi: 10.1001/jama.2019.3805
[33] Flory J H, Hennessy S, Bailey C J, et al. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018[J]. Diabetes Care, 2020, 43(1): 244-246.
doi: 10.2337/dc19-0923
[34] Dungan K M, Povedano S T, Forst T, et al. Once-Weekly Dulaglutide Versus Once-Daily Liraglutide in Metformin-Treated Patients with Type 2 Diabetes(AWARD-6): A Randomised, Open-Label, Phase 3, Non-Inferiority Trial[J]. The Lancet, 2014, 384(9951): 1349-1357.
doi: 10.1016/S0140-6736(14)60976-4
[35] Álvarez-Villalobos N, Treviño-Alvarez A M, González-González J. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes[J]. New England Journal of Medicine, 2016, 375(18): 1797-1799.
doi: 10.1056/NEJMc1611289
[36] Holman R R, Bethel M A, Mentz R J, et al. Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes[J]. The New England Journal of Medicine, 2017, 377(13): 1228-1239.
doi: 10.1056/NEJMoa1612917 pmid: 28910237
[37] Andersen A, Lund A, Knop F K, et al. Glucagon-Like Peptide 1 in Health and Disease[J]. Nature Reviews Endocrinology, 2018, 14(7): 390-403.
doi: 10.1038/s41574-018-0016-2 pmid: 29728598
[38] FDA Approved Drug Products[EB/OL]. [2021-10-25]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022341s036lbl.pdf.
[1] 张晗, 安欣宇, 刘春鹤. 基于多源语义知识图谱的药物知识发现:以药物重定位为实证*[J]. 数据分析与知识发现, 2022, 6(7): 87-98.
[2] 王若佳, 严承希, 郭凤英, 王继民. 基于用户画像的在线健康社区用户流失预测研究*[J]. 数据分析与知识发现, 2022, 6(2/3): 80-92.
[3] 钱旦敏, 曾婷婷, 常侍艺. 突发公共卫生事件下基于在线健康社区用户画像的用户角色研究*[J]. 数据分析与知识发现, 2022, 6(2/3): 93-104.
[4] 蔡妙芝, 李晓瑛, 赵嘉玮, 冯凤翔, 任慧玲. 基于SPO语义三元组的疾病知识发现*[J]. 数据分析与知识发现, 2022, 6(1): 134-144.
[5] 代冰,胡正银. 基于文献的知识发现新近研究综述 *[J]. 数据分析与知识发现, 2021, 5(4): 1-12.
[6] 吴胜男, 田若楠, 蒲虹君, 梁雯琪, 张亚飞, 于琦, 贺培凤. 基于社交媒体的医药领域关联主题预测方法研究*[J]. 数据分析与知识发现, 2021, 5(12): 98-109.
[7] 李贺,刘嘉宇,沈旺,刘锐,金帅岐. 基于模糊认知图的在线健康社区知识推荐研究*[J]. 数据分析与知识发现, 2020, 4(12): 55-67.
[8] 胡正银,刘蕾蕾,代冰,覃筱楚. 基于领域知识图谱的生命医学学科知识发现探析*[J]. 数据分析与知识发现, 2020, 4(11): 1-14.
[9] 胡佳慧,方安,赵琬清,杨晨柳,任慧玲. 面向知识发现的中文电子病历标注方法研究 *[J]. 数据分析与知识发现, 2019, 3(7): 123-132.
[10] 彭昱欣,邓朝华,吴江. 基于社会资本与动机理论的在线健康社区医学专业用户知识共享行为分析*[J]. 数据分析与知识发现, 2019, 3(4): 63-70.
[11] 吴菊华,王煜,黎明,蔡少云. 基于加权知识网络的在线健康社区用户知识发现*[J]. 数据分析与知识发现, 2019, 3(2): 108-117.
[12] 胡哲,查先进,严亚兰. 突发事件情境下在线健康社区用户交互行为研究 *[J]. 数据分析与知识发现, 2019, 3(12): 10-20.
[13] 杨磊,王子润,侯贵生. 基于Q-LDA主题模型的网络健康社区主题挖掘研究 *[J]. 数据分析与知识发现, 2019, 3(11): 52-59.
[14] 胡吉颖,谢靖,钱力,付常雷. 基于知识图谱的科技大数据知识发现平台建设*[J]. 数据分析与知识发现, 2019, 3(1): 55-62.
[15] 王欣, 冯文刚. 在线极端主义和激进化监测技术综述*[J]. 数据分析与知识发现, 2018, 2(10): 2-8.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
版权所有 © 2015 《数据分析与知识发现》编辑部
地址：北京市海淀区中关村北四环西路33号 邮编：100190
电话/传真：(010)82626611-6626，82624938
E-mail:jishu@mail.las.ac.cn